
the simpler. the better. I mostly tweet about $AFMD
Joined October 2018
- Tweets717
- Following0
- Followers169
- Likes466
Pinned Tweet
cc @Roche @genentech
You have on your hand the validated @affimed ICE’s science and you have the chance to be ahead of your competitors. But you need to buy them out, they need your knowledge/competence.
We have entered into a clinical collaboration with @Merck to evaluate DF9001, our EGFR immune engager, in combination with Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in patients with advanced solid tumors expressing EGFR. prnewswire.com/news-releases…
🧬 777 retweeted
Replying to @graham74GC
$AFMD when you’ll buy biotech, please be careful:
- stop buying if it is based in germany;
- stop buying if they have these managers:
- Adi Hoess
- Denise Mueller
- Angus Smith
- Shawn Leland
- Harry Welten
(Pls, check the BoD members as well on the 20-F)
Thank me later.
$AFMD lost faith for those morons at Affimed. New CEO has same charisma of previous one: a total useful idiot for the BoD. They eroded billions from investors. They clearly dont know where the hell are going to. They never had any idea.
Never again a German biotech company.
2
14
3,540
$AFMD trading at 0,15$ pre reverse split. This company is managed by SHAMELESS and INCOMPETENT management and directors. They should cut their salaries at the same % market cut their stock (ie 95%).
Good to know someone with probably deeper knowledge than us is buying despite risk of a (stupid) imminent offering. Maybe Shawn is ready to turn this ship and surprise old destroyed shareholders to be remembered as an hero $AFMD @affimed
$AFMD
We know today that 683 was the buyer of these 270k stocks ( cross)
.@affimed you are still trading at 0,385 pre reverse split (from 11$). No EV.
Care to explain to @lelandspharmd the urgency to make a deal? Better if it is an equity investment by the BP which will be buying you out.
No reason to sell the rights of single assets. Sell the whole.
$AFMD digest the news … talk with analysts/tutes and let the price goes around 50$ first. Then offer small amount of shares to tutes (pipe) or big pharma. Then drop the stellar data. Then sell the co.
cc @lelandspharmd
$AFMD maybe they could get 9 CRs (75%) even at lowest dose level #acimtamig. Will FDA AA this drug?
Trading for 0,38$ … @lelandspharmd better be cooking something special for this broken company. @affimed … in 20 years they have not been able to increase $1 million in value, same value of the IPO. They just killed shareholders. Wake fucking up, you work for investors! $AFMD
2
8
832
.@lelandspharmd AFMD needs a new focused, strong CEO able to finally increase SHs value after ages of disastrous Adi Hoess. Co. has three clinically validated assets: do not destroy value with dilutions, do not offer to friendly-funds. Sale the co. like Trillium did with Pfizer.
1/#China $BGNE BeiGene has registered its MUC1/CD16A bispecific antibody BGB-B3227 clinicaltrials.gov/study/NCT…. The clinical trial, which will involve either monotherapy or combination therapy with a PD-1 antibody for various solid tumors, is expected to start in 2028.
Cord blood cells NK expanded using IL-2/IL-15 & EBV-transformed B-feeder cells combined with mAbs (CD20/CD19) w/ engineered Pin mutations to increase affinity for CD16a confers long-term selective cytotoxicity function @JessyPresumey
jitc.bmj.com/content/12/7/e0…








